Ahn A, Park S-S, Kim Y, Lee JY, Lee J-M, Jung J, Kim M, Min C-K. Minimal residual disease assessment in transplanteligible patients with multiple myeloma: real-world applications of multiparametric flow cytometry- DURAClone (CAREMM-2104). Haematologica; https://doi.org/10.3324/haematol.2024.285278 [Early view].